Evidence map›Paper›PMID 36002804›Full record

ArticleClinical proteomics2022

Proteomics-based evaluation of the mechanism underlying vascular injury via DNA interstrand crosslinks, glutathione perturbation, mitogen-activated protein kinase, and Wnt and ErbB signaling pathways induced by crotonaldehyde.

Ming-Zhang Xie, Jun-Li Liu, Qing-Zu Gao, De-Ying Bo, Lei Wang, Xiao-Chun Zhou, Meng-Meng Zhao, Yu-Chao Zhang, Yu-Jing Zhang, Guo-An Zhao and 1 more

Open access · goldAbstract read
In one paragraph

Article in Clinical proteomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Exposure to Toxic Compounds Using Alternative Smoking Products: Analysis of Empirical Data.International journal of environmental research and public health · 2025
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ming-Zhang XieDepartment of Genetics, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, 453000, Henan, China. 77128425@qq.com.
Jun-Li LiuHenan Key Laboratory of Neurorestoratology, Henan International Joint Laboratory of Neurorestoratology for Senile Dementia, The First Affiliated Hospital of Xinxiang Medical University, Weihui, 453100, Henan, People's Republic of China.
Qing-Zu GaoDepartment of Pathology, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, 453000, Henan, China.
De-Ying BoDepartment of Laboratory, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, 453000, Henan, China.
Lei WangDepartment of Laboratory, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, 453000, Henan, China.
Xiao-Chun ZhouDepartment of Genetics, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, 453000, Henan, China.
Meng-Meng ZhaoDepartment of Genetics, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, 453000, Henan, China.
Yu-Chao ZhangDepartment of Genetics, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, 453000, Henan, China.
Yu-Jing ZhangDepartment of Genetics, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, 453000, Henan, China.
Guo-An ZhaoDepartment of Cardiovascular, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, 453000, Henan, China. tougao3@sohu.com.
Lu-Yang JiaoDepartment of Laboratory, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, 453000, Henan, China. jly@xxmu.edu.cn.
First Affiliated Hospital of Xinxiang Medical University · CN

Funding

Chongqing Xinqiao Hospital, Second Affiliated Hospital of Army Medical University XZZX2022006first affiliated hospital of xinxiang medical university youth science fund project QN-2019-B02key scientific and technological research projects of henan province foundation LHGJ20190456key scientific and technological research projects of henan province foundation LHGJ20220587key scientific and technological research projects of Henan Province Foundation LHGJ20210521technology breakthrough plan of science and technology department of xinxiang GG2019037
6 · The paper itself

Abstract

Crotonaldehyde (CRA)-one of the major environmental pollutants from tobacco smoke and industrial pollution-is associated with vascular injury (VI). We used proteomics to systematically characterize the presently unclear molecular mechanism of VI and to identify new related targets or signaling pathways after exposure to CRA. Cell survival assays were used to assess DNA damage, whereas oxidative stress was determined using colorimetric assays and by quantitative fluorescence study; additionally, cyclooxygenase-2, mitogen-activated protein kinase pathways, Wnt3a, β-catenin, phospho-ErbB2, and phospho-ErbB4 were assessed using ELISA. Proteins were quantitated via tandem mass tag-based liquid chromatography-mass spectrometry and bioinformatics analyses, and 34 differentially expressed proteins were confirmed using parallel reaction monitoring, which were defined as new indicators related to the mechanism underlying DNA damage; glutathione perturbation; mitogen-activated protein kinase; and the Wnt and ErbB signaling pathways in VI based on Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and protein-protein interaction network analyses. Parallel reaction monitoring confirmed significant (p < 0.05) upregulation (> 1.5-fold change) of 23 proteins and downregulation (< 0.667-fold change) of 11. The mechanisms of DNA interstrand crosslinks; glutathione perturbation; mitogen-activated protein kinase; cyclooxygenase-2; and the Wnt and ErbB signaling pathways may contribute to VI through their roles in DNA damage, oxidative stress, inflammation, vascular dysfunction, endothelial dysfunction, vascular remodeling, coagulation cascade, and the newly determined signaling pathways. Moreover, the Wnt and ErbB signaling pathways were identified as new disease pathways involved in VI. Taken together, the elucidated underlying mechanisms may help broaden existing understanding of the molecular mechanisms of VI induced by CRA.

Indexed as

CrotonaldehydeDifferentially expressed proteinsIndicatorsVascular injuryWnt and ErbB signaling pathways

Identifiers

PMID36002804
PMCPMC9400244
OpenAlexW4292879317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.